![](/img/cover-not-exists.png)
865Liposomal recombinant human superoxide dismutase for the treatment of peyronie's disease: A randomized placebo-controlled double-blind clinical study
C. Riedl, P. Steming, F. Langmann, G. Galle, P.F. Engelhardt, B. Vcelar, K. Vorauer, A. Wagner, H. Katinger, H. PflügerVolume:
4
Year:
2005
Language:
english
DOI:
10.1016/s1569-9056(05)80869-3
File:
PDF, 209 KB
english, 2005